The CDRH 2023 annual report says the Center approved the most novel devices in its history.
Canada health minister Mark Holland says he has been assured by top U.S. officials that the U.S. does not intend to harm Canadas drug supply by approv...
CDRH Office of In Vitro Diagnostics director Timothy Stenzel retires after almost six years as head of diagnostic devices.
FDA publishes a guidance on enhanced drug distribution security at the package level.
FDA sends Satsuma Pharmaceuticals a complete response letter on its NDA for STS101 (dihydroergotamine nasal powder), an investigational product for th...
Percussionaire recalls its Distal Phasitron, part: S20020, for use with the Percussionaire VDR-4 ventilator control driver due to the potential for th...
FDA says the Megadyne recall of four models of patient return electrodes following reports of patient burns is Class 1.
The Pittsburgh Post-Gazette says GAO has accepted a request from two senators to look into FDA oversight of medical device adverse events and recalls.